Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Takara Leah Stanley, M.D.

Co-Author

This page shows the publications co-authored by Takara Stanley and Lindsay Fourman.
Connection Strength

3.170
  1. Placental Vascular Abnormalities in Association With Prenatal and Long-Term Health Characteristics Among HIV-Exposed Uninfected Adolescents and Young Adults. J Acquir Immune Defic Syndr. 2021 09 01; 88(1):103-109.
    View in: PubMed
    Score: 0.245
  2. Growth Hormone Releasing Hormone Reduces Circulating Markers of Immune Activation in Parallel with Effects on Hepatic Immune Pathways in Individuals with HIV-infection and Nonalcoholic Fatty Liver Disease. Clin Infect Dis. 2021 08 16; 73(4):621-630.
    View in: PubMed
    Score: 0.245
  3. Clinical Predictors of Liver Fibrosis Presence and Progression in Human Immunodeficiency Virus-Associated Nonalcoholic Fatty Liver Disease. Clin Infect Dis. 2021 06 15; 72(12):2087-2094.
    View in: PubMed
    Score: 0.242
  4. Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach. Sci Rep. 2021 05 18; 11(1):10485.
    View in: PubMed
    Score: 0.241
  5. Reply to Maurice and Lemoine. Clin Infect Dis. 2021 03 01; 72(5):909.
    View in: PubMed
    Score: 0.237
  6. Relationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease. J Clin Endocrinol Metab. 2021 01 23; 106(2):e520-e533.
    View in: PubMed
    Score: 0.235
  7. Effect of recombinant human growth hormone on liver fat content in young adults with nonalcoholic fatty liver disease. Clin Endocrinol (Oxf). 2021 02; 94(2):183-192.
    View in: PubMed
    Score: 0.231
  8. Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD. JCI Insight. 2020 08 20; 5(16).
    View in: PubMed
    Score: 0.229
  9. Association of In Utero HIV Exposure With Obesity and Reactive Airway Disease in HIV-Negative Adolescents and Young Adults. J Acquir Immune Defic Syndr. 2020 02 01; 83(2):126-134.
    View in: PubMed
    Score: 0.220
  10. Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial. Lancet HIV. 2019 12; 6(12):e821-e830.
    View in: PubMed
    Score: 0.215
  11. Comparison of visceral fat measurement by dual-energy X-ray absorptiometry to computed tomography in HIV and non-HIV. Nutr Diabetes. 2019 02 25; 9(1):6.
    View in: PubMed
    Score: 0.206
  12. Insulin-like growth factor 1 inversely relates to monocyte/macrophage activation markers in HIV. AIDS. 2018 04 24; 32(7):927-932.
    View in: PubMed
    Score: 0.195
  13. Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV. AIDS. 2017 10 23; 31(16):2253-2259.
    View in: PubMed
    Score: 0.188
  14. Differential relationships of hepatic and epicardial fat to body composition in HIV. Physiol Rep. 2017 Oct; 5(19).
    View in: PubMed
    Score: 0.188
  15. Intramyocardial Triglycerides Among Women With vs Without HIV: Hormonal Correlates and Functional Consequences. J Clin Endocrinol Metab. 2019 12 01; 104(12):6090-6100.
    View in: PubMed
    Score: 0.054
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.